Metoclopramide and the Length of First Stage of Labor , a Randomized Controlled Trial

• Status: Not yet recruiting
• Trial end date: 2022-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

Reducing the length of labor is a highly desirable goal of intrapartum care, both from a perspective of maternal and fetal well-being and for the providers of the birth services. Avoiding a long, protracted labor entails shorter exposure to pain anxiety and stress and would translate into a major improvement in maternal satisfaction with the childbirth experience.

Prolonged labor can lead to increased maternal and neonatal morbidity and mortality such as rupture of the uterus, postpartum hemorrhage, puerperal sepsis, and maternal death. Prolonged labor may be due to maternal age, premature rupture of membrane, epidural analgesia and the secretion of high levels of maternal stress hormones.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Cairo University
• Treatments: Metoclopramide

Criteria

Inclusion Criteria:

• primigravida

• singleton pregnancy

• termgestation (37-42 weeks)

• sure reliable dated

• vertex presentation , occipito-anterior position

• regular uterine contractions at every 5 minutes,each lasting for 20 seconds

• cervical dilatation of 5 cm

• with or without rupture of membrane

• no evidence of maternal or fetal distress

Exclusion Criteria:

• chorioamnionitis

• scarred uterus e.g. myomectomy

• cephalopelvic dispropotion

• history of cervical surgery or injury

• hypersensitivity to metoclopramide